Smallpox vaccine adverse events among civilians--United States, February 18-24, 2003.MMWR Morb Mortal Wkly Rep. 2003 Feb 28; 52(8):156-7.MM
Abstract
During the civilian smallpox vaccination program, CDC and state health departments are conducting surveillance for vaccine-associated adverse events. In the first stage of the program, active surveillance is being conducted for potentially life-threatening, moderate-to-severe, and other serious adverse events and for vaccinia transmission to contacts of vaccinees (Table). Nonserious events are reported through passive surveillance and are expected to be underreported. This report summarizes smallpox vaccine adverse events reported among civilians vaccinated as of February 21, 2003, and received by CDC from the Vaccine Adverse Event Reporting System (VAERS) as of February 24.
Links
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
12625500
Citation
Centers for Disease Control and Prevention (CDC). "Smallpox Vaccine Adverse Events Among civilians--United States, February 18-24, 2003." MMWR. Morbidity and Mortality Weekly Report, vol. 52, no. 8, 2003, pp. 156-7.
Centers for Disease Control and Prevention (CDC). Smallpox vaccine adverse events among civilians--United States, February 18-24, 2003. MMWR Morb Mortal Wkly Rep. 2003;52(8):156-7.
Centers for Disease Control and Prevention (CDC). (2003). Smallpox vaccine adverse events among civilians--United States, February 18-24, 2003. MMWR. Morbidity and Mortality Weekly Report, 52(8), 156-7.
Centers for Disease Control and Prevention (CDC). Smallpox Vaccine Adverse Events Among civilians--United States, February 18-24, 2003. MMWR Morb Mortal Wkly Rep. 2003 Feb 28;52(8):156-7. PubMed PMID: 12625500.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Smallpox vaccine adverse events among civilians--United States, February 18-24, 2003.
A1 - ,,
PY - 2003/3/11/pubmed
PY - 2003/3/12/medline
PY - 2003/3/11/entrez
SP - 156
EP - 7
JF - MMWR. Morbidity and mortality weekly report
JO - MMWR Morb Mortal Wkly Rep
VL - 52
IS - 8
N2 - During the civilian smallpox vaccination program, CDC and state health departments are conducting surveillance for vaccine-associated adverse events. In the first stage of the program, active surveillance is being conducted for potentially life-threatening, moderate-to-severe, and other serious adverse events and for vaccinia transmission to contacts of vaccinees (Table). Nonserious events are reported through passive surveillance and are expected to be underreported. This report summarizes smallpox vaccine adverse events reported among civilians vaccinated as of February 21, 2003, and received by CDC from the Vaccine Adverse Event Reporting System (VAERS) as of February 24.
SN - 0149-2195
UR - https://www.unboundmedicine.com/medline/citation/12625500/Smallpox_vaccine_adverse_events_among_civilians__United_States_February_18_24_2003_
L2 - http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5208a4.htm
DB - PRIME
DP - Unbound Medicine
ER -